{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:09:50Z","timestamp":1793642990230,"version":"4.5.1"},"reference-count":47,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T00:00:00Z","timestamp":1337040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:p><jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>pstein\u2013<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>arr virus (<jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>) infects various types of lymphocytes and is associated with not only <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> cell\u2010origin lymphoma, but also <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> or natural killer cell lymphoproliferative diseases (<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NK LPD<\/jats:styled-content>). Recently, we established a novel assay to identify <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010infected cells using <jats:styled-content style=\"fixed-case\">FISH<\/jats:styled-content>. Using this assay, dual staining with antibodies to both surface antigens and an <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010encoded small <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">EBER<\/jats:styled-content>) probe can be performed. In the present study, we applied this recently developed <jats:styled-content style=\"fixed-case\">FISH<\/jats:styled-content> assay to <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010associated <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NK LPD<\/jats:styled-content> to confirm its diagnostic utility. Using <jats:styled-content style=\"fixed-case\">FISH<\/jats:styled-content>, we prospectively analyzed peripheral blood from patients with suspected <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010associated <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NK LPD<\/jats:styled-content>. The results were compared with those obtained using immunobead sorting followed by quantitative <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>. In all, 26 patients were included study. Using <jats:styled-content style=\"fixed-case\">FISH<\/jats:styled-content>, 0.15\u201367.0% of peripheral blood lymphocytes were found to be positive for <jats:styled-content style=\"fixed-case\">EBER<\/jats:styled-content>. Dual staining was used to determine <jats:styled-content style=\"fixed-case\">EBER<\/jats:styled-content>\u2010positive cell phenotypes in 23 of 26 subjects (88.5%). In five of seven patients with hydroa vacciniforme\u2010like lymphoma (an <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010positive cutaneous <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> cell lymphoma), <jats:styled-content style=\"fixed-case\">EBER<\/jats:styled-content>\u2010positive cells were identified as <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>3<jats:sup>+<\/jats:sup><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4<jats:sup>\u2212<\/jats:sup><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8<jats:sup>\u2212\u00a0<\/jats:sup><jats:styled-content style=\"fixed-case\">TCR<\/jats:styled-content>\u03b3\u03b4<jats:sup>+<\/jats:sup> T cells. Furthermore, in a 25\u2010year\u2010old male patient with systemic <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010positive <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> cell <jats:styled-content style=\"fixed-case\">LPD<\/jats:styled-content>, two lymphocyte lineages were positive for <jats:styled-content style=\"fixed-case\">EBER<\/jats:styled-content>:<jats:styled-content style=\"fixed-case\"> CD<\/jats:styled-content>4<jats:sup>+<\/jats:sup><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8<jats:sup>\u2212<\/jats:sup> and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4<jats:sup>\u2212<\/jats:sup><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8<jats:sup>+<\/jats:sup><jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> cells. Thus, we confirmed that our newly developed assay is useful for quantifying and characterizing <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010infected lymphocytes in <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010associated <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">NK LPD<\/jats:styled-content> and that it can be used not only to complement the pathological diagnosis, but also to clarify the pathogenesis and to expand the spectrum of <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\u2010associated diseases. (<jats:italic>Cancer Sci,<\/jats:italic> doi: 10.1111\/j.1349\u20107006.2012.02305.x, 2012)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2012.02305.x","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T14:10:28Z","timestamp":1334239828000},"page":"1481-1488","source":"Crossref","is-referenced-by-count":31,"title":["Application of flow cytometric <i>in situ<\/i> hybridization assay to <scp>E<\/scp>pstein\u2013<scp>B<\/scp>arr virus\u2010associated <scp>T<\/scp>\/natural killer cell lymphoproliferative diseases"],"prefix":"10.1111","volume":"103","author":[{"given":"Shinji","family":"Kawabe","sequence":"first","affiliation":[{"name":"Department of Pediatrics Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Gotoh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimikazu","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Haematology and Oncology Children's Medical Centre, Nagoya First Red Cross Hospital  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Virology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Virology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Virology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008173430707"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2702"},{"key":"e_1_2_7_4_1","first-page":"2655","volume-title":"Virology","author":"Rickinson AB","year":"2006"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06835.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp064"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.10.3173"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.280"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.505"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2008.02213.x"},{"key":"e_1_2_7_11_1","first-page":"278","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Quintanilla\u2010Martinez L","year":"2008"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e3181d68381"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.03976.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-381921"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.582"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212103272403"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001001)89:7<1586::AID-CNCR24>3.0.CO;2-1"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(02)00078-1"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/605610"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.033712-0"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","article-title":"Quantitative analysis of Epstein\u2013Barr virus load by using a real\u2010time PCR assay","volume":"37","author":"Kimura H","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03087.x"},{"key":"e_1_2_7_23_1","first-page":"276","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan JKC","year":"2008"},{"key":"e_1_2_7_24_1","first-page":"285","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan JKC","year":"2008"},{"key":"e_1_2_7_25_1","first-page":"306","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Pileri SA","year":"2008"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20398"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1086\/427239"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/653737"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20622"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-1578(10)60580-6"},{"key":"e_1_2_7_33_1","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1182\/blood.V94.9.3094","article-title":"Rapid determination of Epstein\u2013Barr virus\u2010specific CD8(+) T\u2010cell frequencies by flow cytometry","volume":"94","author":"Kuzushima K","year":"1999","journal-title":"Blood"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.013482-0"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.7532375.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(02)00119-1"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2004.03.012"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.01.014"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-285452"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00129039-200203000-00002"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04862.x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06038.x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.587"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10512.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.461"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.6.2272"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2781"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.5940"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2012.02305.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2012.02305.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:18:13Z","timestamp":1697440693000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2012.02305.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1349-7006.2012.02305.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02305.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,15]]}}}